Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor effects of CCI-779 in breast cancer: final results of a phase II trial

Dec. 5, 2003

Celecoxib supplementation allows more breast-conserving surgery for LABC

Dec. 5, 2003

Bevacizumab plus docetaxel in metastatic breast cancer

Dec. 5, 2003

In vitro and in vivo antitumor effects of GW-572016

Dec. 5, 2003

Novel sst receptor modulators prepared and tested at ChemBridge

Dec. 5, 2003

Ortho-McNeil scientists discover new androgen receptor modulators

Dec. 5, 2003

Protein prenyltransferase inhibitors newly identified at PPD Discovery

Dec. 5, 2003

In vivo efficacy of drugs targeting tumor vasculature

Dec. 4, 2003

Telcyta awarded fast track status for third-line therapy of NSCLC

Dec. 4, 2003

Xcytrin granted fast track status for brain metastases in NSCLC patients

Dec. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...